+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Oligonucleotide Synthesis - Market Analysis, Trends, and Forecasts

  • ID: 4805929
  • Report
  • February 2020
  • Region: Global
  • 347 pages
  • Global Industry Analysts, Inc
1 of 3

FEATURED COMPANIES

  • ATDBIO LTD.
  • BIO-SYNTHESIS INC.
  • EUROGENTEC
  • GENEDESIGN
  • MERCK KGAA
  • NITTO DENKO AVECIA INC.
  • MORE
Oligonucleotide Synthesis market worldwide is projected to grow by US$1.6 Billion, driven by a compounded growth of 10.6%. Synthesized Oligonucleotides, one of the segments analyzed and sized in this study, displays the potential to grow at over 11.1%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$1.6 Billion by the year 2025, Synthesized Oligonucleotides will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 9.4% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$66.1 Million to the region's size and clout in the next 5 to 6 years. Over US$54.1 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Synthesized Oligonucleotides will reach a market size of US$78.9 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 13.8% over the next couple of years and add approximately US$394.7 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others,
  • ATDBio Ltd.
  • Bio-Synthesis Inc.
  • Eurogentec
  • GE Healthcare Life Sciences
  • GeneDesign, Inc.
  • GenScript Biotech Corporation
  • Integrated DNA Technologies (IDT), Inc.
  • LGC Biosearch Technologies
  • Merck KgaA
  • Nitto Denko Avecia Inc.
  • Thermo Fisher Scientific, Inc.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • ATDBIO LTD.
  • BIO-SYNTHESIS INC.
  • EUROGENTEC
  • GENEDESIGN
  • MERCK KGAA
  • NITTO DENKO AVECIA INC.
  • MORE

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Oligonucleotide Synthesis Market Set for a Steady Growth

Oligonucleotide Synthesis Market by End-use: 2018

Oligonucleotide Synthesis Market Breakdown by Geographic Region: 2018

Global Competitor Market Shares

Oligonucleotide Synthesis Competitor Market Share Scenario Worldwide (in %): 2019 & 2025

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

Growing Demand for Oligonucleotide-based Drugs to Boost the Oligonucleotide Synthesis Market

Increased Pharma R&D to Spur the Market Growth

FDA-Approved Oligonucleotide-based Drugs Promise Huge Potential for Market Growth

Recent Approval of Exondys 51 and Nusinersen Aids in Treatment of Inherited Diseases

Oligonucleotide Drugs Aid Effective Treatment of Neurodegenerative Disorders

Inotersen – The Second FDA Approved Drug for Polyneuropathy, Following Onpattro

Market Outlook and Advancements in Antisense Drugs

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

Market Facts & Figures

US Oligonucleotide Synthesis Market Share (in %) by Company: 2019 & 2025

Market Analytics

CANADA

JAPAN

CHINA

EUROPE

Market Facts & Figures

European Oligonucleotide Synthesis Market: Competitor Market Share Scenario (in %) for 2019 & 2025

Market Analytics

FRANCE

GERMANY

ITALY

UNITED KINGDOM

SPAIN

RUSSIA

REST OF EUROPE

ASIA-PACIFIC

AUSTRALIA

INDIA

SOUTH KOREA

REST OF ASIA-PACIFIC

LATIN AMERICA

ARGENTINA

BRAZIL

Oligonucleotide Synthesis Market by Application: 2014-2025

MEXICO

REST OF LATIN AMERICA

MIDDLE EAST

IRAN

ISRAEL

SAUDI ARABIA

UNITED ARAB EMIRATES

REST OF MIDDLE EAST

AFRICA

IV. COMPETITION

ATDBIO LTD.

BIO-SYNTHESIS INC.

EUROGENTEC

GE HEALTHCARE LIFE SCIENCES

GENSCRIPT BIOTECH CORPORATION

GENEDESIGN

INTEGRATED DNA TECHNOLOGIES (IDT), INC.

LGC BIOSEARCH TECHNOLOGIES

MERCK KGAA

NITTO DENKO AVECIA INC.

THERMO FISHER SCIENTIFIC

V. CURATED RESEARCH

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • ATDBIO LTD.
  • BIO-SYNTHESIS INC.
  • EUROGENTEC
  • GE HEALTHCARE LIFE SCIENCES
  • GENSCRIPT BIOTECH CORPORATION
  • GENEDESIGN
  • INTEGRATED DNA TECHNOLOGIES (IDT), INC.
  • LGC BIOSEARCH TECHNOLOGIES
  • MERCK KGAA
  • NITTO DENKO AVECIA INC.
  • THERMO
Note: Product cover images may vary from those shown
Adroll
adroll